RCKT Rocket Pharmaceuticals, Inc.

NASDAQ
$3.35

Rocket Pharmaceuticals, Inc. (RCKT) Insider Activity

What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.

30D 90D 6M 1Y
Insider signal In line Selling ran in line with RCKT's own trailing one-year pace, with 0% of sale value under a prearranged plan.
Cluster activity 0 buyers in the last 30 days 0 buyers in the last 90 days 4 sellers in the last 90 days
Insiders buying
1
1 transaction
Insiders selling
6
28 transactions
Purchases
$34.4K
10,000 shares
Sales
$722.1K
211,598 shares
Net activity
-$687.7K
purchases less sales

How much of that selling was preplanned? 0% planned / 100% discretionary

10b5-1 plan sales $0 0 transactions · 0 shares
Discretionary sales $722.1K 28 transactions · 211,598 shares

Largest single sale: $171.8K.

Where they traded

Buy Sell Dot area is proportional to transaction value.

Last open-market purchase: January 2, 2026 , by Bjork Elisabeth .

Recent open-market activity

Date Insider Role Action Shares Price Value Held after
Shah Gaurav CEO Sell 2,293 $3.38 $7.8K 1,056,594 −0.2% of holding
Wilson Martin General Counsel Sell 631 $3.38 $2.1K 673,853 −0.1% of holding
Wilson Martin General Counsel Sell 3,493 $3.38 $11.8K 674,484 −0.5% of holding
Shah Gaurav CEO Sell 2,837 $3.38 $9.6K 1,058,887 −0.3% of holding
Stevens Christopher James Chief Operating Officer Sell 36,658 $3.50 $128.3K 505,784 −6.8% of holding
Chaudhuri Sarbani See Remarks Sell 4,701 $3.50 $16.4K 262,809 −1.8% of holding
Shah Gaurav CEO Sell 55,684 $3.09 $171.8K 1,061,724 −5% of holding
Shah Gaurav CEO Sell 2,409 $3.01 $7.3K 1,040,918 −0.2% of holding
Wilson Martin General Counsel Sell 662 $3.01 $2.0K 677,977 −0.1% of holding
Militello John See Remarks Sell 384 $3.01 $1.2K 89,780 −0.4% of holding
Wilson Martin General Counsel Sell 3,361 $3.61 $12.1K 678,639 −0.5% of holding
Shah Gaurav CEO Sell 2,728 $3.61 $9.8K 1,043,327 −0.3% of holding
Militello John See Remarks Sell 855 $3.61 $3.1K 90,164 −0.9% of holding
Chaudhuri Sarbani See Remarks Sell 17,650 $3.84 $67.7K 267,510 −6.2% of holding
Shah Gaurav CEO Sell 5,990 $3.34 $20.0K 1,046,055 −0.6% of holding
Wilson Martin General Counsel Sell 1,376 $3.34 $4.6K 682,000 −0.2% of holding
Militello John See Remarks Sell 1,157 $3.34 $3.9K 91,019 −1.3% of holding
Shah Gaurav CEO Sell 12,279 $3.31 $40.7K 1,052,045 −1.2% of holding
Wilson Martin General Counsel Sell 12,253 $3.31 $40.6K 683,376 −1.8% of holding
Militello John See Remarks Sell 3,726 $3.31 $12.3K 92,176 −3.9% of holding
Bjork Elisabeth Director Buy 10,000 $3.44 $34.4K 50,000
Shah Gaurav CEO Sell 6,276 $2.98 $18.7K 778,296 −0.8% of holding
Schwartz Jonathan David See Remarks Sell 2,545 $2.98 $7.6K 299,064 −0.8% of holding
Wilson Martin General Counsel Sell 1,646 $2.98 $4.9K 383,816 −0.4% of holding
Militello John See Remarks Sell 1,086 $2.98 $3.2K 65,920 −1.6% of holding
Militello John 4 fills See Remarks Sell 28,918 $3.96 $114.6K 76,083 −27.5% of holding

Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.